TAG:
managed care contracts
Busy Year Demonstrated By Top Ten Lab Stories
By Robert Michel | From the Volume XIV No. 17 – December 10, 2007 Issue
CEO SUMMARY: As it turns out, 2007 has been an action-packed year with lots of events, plenty of changes, and the promise of even faster evolution across all sectors of the lab testing marketplace. THE D…
Shiel Medical Lab Grows In Tough NYC Market
By Robert Michel | From the Volume XIV No. 14 – October 8, 2007 Issue
CEO SUMMARY: There’s a new lab player emerging in the New York metropolitan market. Shiel Medical Laboratory of Brooklyn, New York, is growing steadily and now reports $50 million in annual revenue. It is taking full advantage of the managed care contracting turmoil and adding new clien…
Quest, LabCorp Slug It Out In Battle for Market Share
By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue
CEO SUMMARY: In reporting second quarter earnings, both Laboratory Corporation of America and Quest Diagnostics Incorporated discussed market developments. There were no surprises in the comments made by executives of both companies. Quest Diagnostics emphasized that it is hanging on to a…
Intense Competition for Market Share in New York
By R. Lewis Dark | From the Volume XIV No. 10 – July 16, 2007 Issue
ONE OF THE MOST TURBULENT MARKETS FOR LAB SERVICES TODAY is New York City and the Tri-State area of New York, New Jersey, and Connecticut. This is ground zero in the fight for market share between Quest Diagnostics Incorporated and Laboratory Corporation of America a…
Community Hospital Builds Thriving Lab Outreach Program
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: When 330-bed Botsford Hospital of Farmington Hills, Michigan, got interested in laboratory outreach 10 years ago, it brought in a new laboratory leader, invested in new analyzers and informatics, and then let the quality of the operation attract new business from the communit…
Quest Wants It Both Ways with Payer Contracts
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: Once again, public laboratory companies are pursuing short-term strategies that promise competitive advantage to themselves. But these strategies also carry long term risks that could burden the entire laboratory industry. Contradictions in the current cycle of competition fo…
Labs Can Be Misguided by Pull-Through Test Myth
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: For the first time in almost eight years, there are major disruptions to the status quo in managed care contracting for laboratory testing services. As was true in the 1990s, national lab companies are pursuing exclusive national contracts with the nation’s…
Will OIG Reconsider Policy on Discriminatory Pricing?
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
HEIGHTENED COMPETITION in recent months for exclusive managed care contracts between the two blood brothers may trigger the law of unintended consequences. One such consequence could be renewed interest by Medicare regulators in what they call “discriminatory billing.” “In 2003, the federal …
Aetna Says: LabCorp Is Out & Quest Diagnostics Is In
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
CEO SUMMARY: January 1, 2007 can be considered the start of a new epoch in managed care contracting for lab test services. News of Aetna’s decision to favor Quest Diagnostics Incorporated with a five-year contract as its only national laboratory provider shows the direction this new epo…
Pumping Up Performance of Lab Billing & Collections
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
CEO SUMMARY: Coding, billing, collections, and compliance continue to grow in complexity, making management of the lab’s revenue cycle ever more difficult. One by one, a number of the nation’s largest laboratories are taking steps to automate management of their revenue cycle by utili…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized